About Bluefield Solar Bluefield Solar is a UK income fund focused, primarily, on acquiring and managing UK-based solar projects to generate renewable energy for periods of typically 25 years or longer. Not less than 75% of the Company s gross assets will be invested into UK solar assets. The Company can also invest up to 25% of its gross assets into onshore wind, hydro and storage technologies. Its primary objective is to deliver to its shareholders stable, long term sterling income via quarterly dividends. The majority of the Group s revenue streams are regulated and non-correlated to the UK energy market. Bluefield Solar owns and operates one of the UK s largest, diversified portfolios of solar assets with a combined installed power capacity in excess of 612 MWp.
[HK]高门集团:有关申万宏源证券(香港)有限公司为及代表施清流先生发出强制性无条件现金要约以收购高门集团有限公司的全部已发行股份(要约人及其一致行动人士已拥有或同意将予收购的股份除外)综合文件- CFi CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]基石科技控股:(1) 有关涉及关连人士根据特别授权认购新股份之关连交易;及(2) 股东特别大会通告- CFi CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
Revive Therapeutics Announces $10 Million Bought Deal Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Revive Therapeutics Ltd. a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that is has entered into an agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters pursuant to which the … /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /
Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE: RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that is has entered into an agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), pursuant